BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12889007)

  • 1. In vitro bioactivity of silicon-substituted hydroxyapatites.
    Balas F; Pérez-Pariente J; Vallet-Regí M
    J Biomed Mater Res A; 2003 Aug; 66(2):364-75. PubMed ID: 12889007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dip coated silicon-substituted hydroxyapatite films.
    Hijón N; Victoria Cabañas M; Peña J; Vallet-Regí M
    Acta Biomater; 2006 Sep; 2(5):567-74. PubMed ID: 16828579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyapatite/SiO(2)-CaO-P(2)O(5) glass materials: in vitro bioactivity and biocompatibility.
    Padilla S; Román J; Sánchez-Salcedo S; Vallet-Regí M
    Acta Biomater; 2006 May; 2(3):331-42. PubMed ID: 16701892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compositional dependence on the in vitro bioactivity of invert or conventional bioglasses in the Si-Ca-Na-P system.
    Lebecq I; Désanglois F; Leriche A; Follet-Houttemane C
    J Biomed Mater Res A; 2007 Oct; 83(1):156-68. PubMed ID: 17390369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suitability evaluation of sol-gel derived Si-substituted hydroxyapatite for dental and maxillofacial applications through in vitro osteoblasts response.
    Balamurugan A; Rebelo AH; Lemos AF; Rocha JH; Ventura JM; Ferreira JM
    Dent Mater; 2008 Oct; 24(10):1374-80. PubMed ID: 18417203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Wet synthesis and characterization of fluoride-substituted hydroxyapatite].
    Zhang Y; Fu T; Xu K; An H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Jun; 18(2):173-6. PubMed ID: 11450527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ions in aqueous media on hydroxyapatite induction by silica gel and its relevance to bioactivity of bioactive glasses and glass-ceramics.
    Li P; Ohtsuki C; Kokubo T; Nakanishi K; Soga N; Nakamura T; Yamamuro T
    J Appl Biomater; 1993; 4(3):221-9. PubMed ID: 10146306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical analysis of silica doped hydroxyapatite biomaterials consolidated by a spark plasma sintering method.
    Xu JL; Khor KA
    J Inorg Biochem; 2007 Feb; 101(2):187-95. PubMed ID: 17095092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of calcium disilicide-induced calcification of crystalline silicon surfaces in simulated body fluid under zero bias.
    Seregin VV; Coffer JL
    J Biomed Mater Res A; 2008 Oct; 87(1):15-24. PubMed ID: 18080303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility of dense hydroxyapatite prepared using an SPS process.
    Nakahira A; Tamai M; Aritani H; Nakamura S; Yamashita K
    J Biomed Mater Res; 2002 Dec; 62(4):550-7. PubMed ID: 12221703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro degradation, bioactivity, and cytocompatibility of calcium silicate, dimagnesium silicate, and tricalcium phosphate bioceramics.
    Ni S; Chang J
    J Biomater Appl; 2009 Aug; 24(2):139-58. PubMed ID: 18801892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomimetic deposition of apatite coating on surface-modified NiTi alloy.
    Gu YW; Tay BY; Lim CS; Yong MS
    Biomaterials; 2005 Dec; 26(34):6916-23. PubMed ID: 15941583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomimetic growth of apatite on hydrogen-implanted silicon.
    Liu X; Fu RK; Poon RW; Chen P; Chu PK; Ding C
    Biomaterials; 2004 Nov; 25(25):5575-81. PubMed ID: 15159073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous structure and in vitro degradation behavior of wet-chemically derived nanocrystalline silicon-containing hydroxyapatite particles.
    Hayakawa S; Kanaya T; Tsuru K; Shirosaki Y; Osaka A; Fujii E; Kawabata K; Gasqueres G; Bonhomme C; Babonneau F; Jäger C; Kleebe HJ
    Acta Biomater; 2013 Jan; 9(1):4856-67. PubMed ID: 22922250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface modifications of glass-reinforced hydroxyapatite composites.
    Santos JD; Jha LJ; Monteiro FJ
    Biomaterials; 1995 May; 16(7):521-6. PubMed ID: 7492715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in-vitro bioactivity of mesoporous bioactive glasses.
    Yan X; Huang X; Yu C; Deng H; Wang Y; Zhang Z; Qiao S; Lu G; Zhao D
    Biomaterials; 2006 Jun; 27(18):3396-403. PubMed ID: 16504289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural studies of bioactivity in sol-gel-derived glasses by X-ray spectroscopy.
    Skipper LJ; Sowrey FE; Pickup DM; Fitzgerald V; Rashid R; Drake KO; Lin Z; Saravanapavan P; Hench LL; Smith ME; Newport RJ
    J Biomed Mater Res A; 2004 Aug; 70(2):354-60. PubMed ID: 15227682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early apatite deposition and osteoblast growth on plasma-sprayed dicalcium silicate coating.
    Liu X; Xie Y; Ding C; Chu PK
    J Biomed Mater Res A; 2005 Sep; 74(3):356-65. PubMed ID: 16010667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of the bioactivity of three materials for dental applications.
    Lööf J; Svahn F; Jarmar T; Engqvist H; Pameijer CH
    Dent Mater; 2008 May; 24(5):653-9. PubMed ID: 17727942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface modification of P(EMA-co-HEA)/SiO2 nanohybrids for faster hydroxyapatite deposition in simulated body fluid?
    Vallés Lluch A; Ferrer GG; Pradas MM
    Colloids Surf B Biointerfaces; 2009 May; 70(2):218-25. PubMed ID: 19185471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.